Browse studies, page 669

Page 669 of 1,298, newest first. Search them all at once, ranked by relevance, in Evidence Hub.

• Managing the older bronchitis patient Geriatrics, 1985
• Erdosteine for COPD exacerbations Drug and therapeutics bulletin, 2008
• A systematic review on how primary care electronic medical record data have been used for antimicrobial stewardship Antimicrobial Stewardship & Healthcare Epidemiology, 2025
• Gemifloxacin: a new fluoroquinolone approved for treatment of respiratory infections The Annals of pharmacotherapy, 2004
• Barriers to the effective management of respiratory tract infections in the community Infection, 2001
• Sputum antimicrobial levels and clinical outcome in bronchitis Seminars in respiratory infections, 1991
• Cefditoren: a clinical overview The new microbiologica, 2023
• Telithromycin: a ketolide antibiotic for treatment of respiratory tract infections Clinical infectious diseases : an official publication of the Infectious Diseases Society of America, 2005
• Microbiology of newer fluoroquinolones: focus on respiratory pathogens Diagnostic microbiology and infectious disease, 2002
• Community-acquired lower respiratory tract infections: clinical experience with beta-lactam/beta-lactamase inhibitors International journal of clinical practice. Supplement, 2002
• Fluoroquinolones in respiratory infections Seminars in respiratory infections, 1991
• Telithromycin: an oral ketolide for respiratory infections Pharmacotherapy, 2001
• Clarithromycin extended-release in community-acquired respiratory tract infections Expert opinion on pharmacotherapy, 2005
• 10 years' experience with the pneumococcal quinolone moxifloxacin Expert review of anti-infective therapy, 2009
• Cefditoren in upper and lower community-acquired respiratory tract infections Drug design, development and therapy, 2011
• Bacterial Vaccinations in Patients with Chronic Obstructive Pulmonary Disease Vaccines, 2024
• Chemotherapy for chronic bronchitis. Controversies Presse medicale (Paris, France : 1983), 1995
• Cefditoren and community-acquired lower respiratory tract infections (corrected) Revista espanola de quimioterapia : publicacion oficial de la Sociedad Espanola de Quimioterapia, 2009
• Short-course antibiotic therapy for infections with a single causative pathogen The Journal of international medical research, 2000
• Evaluation and cost assessment of fluoroquinolones in community-acquired respiratory infections Expert opinion on pharmacotherapy, 2002
• Gatifloxacin, an advanced 8-methoxy fluoroquinolone Pharmacotherapy, 2001
• Review of cefditoren, an advanced-generation, broad-spectrum oral cephalosporin Clinical therapeutics, 2001
• Telithromycin: the first ketolide for the treatment of respiratory infections American journal of health-system pharmacy : AJHP : official journal of the American Society of Health-System Pharmacists, 2005
• Clinical management of respiratory tract infections in the community: experience with telithromycin Infection, 2001
• Prulifloxacin: a new antibacterial fluoroquinolone Expert review of anti-infective therapy, 2006
• Cefditoren, a new aminothiazolyl cephalosporin Pharmacotherapy, 2002
• Moxifloxacin in respiratory tract infections Expert opinion on pharmacotherapy, 2005
• The role of fluoroquinolones in respiratory tract infections The Journal of antimicrobial chemotherapy, 1997
• The ketolides: a critical review Drugs, 2002
• Clinical aspects of Chlamydia pneumoniae infection Presse medicale (Paris, France : 1983), 1995
• Towards a vaccine for chronic obstructive pulmonary disease Internal medicine journal, 2012
• The Role of Non-Typeable Haemophilus influenzae Biofilms in Chronic Obstructive Pulmonary Disease Frontiers in cellular and infection microbiology, 2021
• Pharmacotherapy for lower respiratory tract infections Expert opinion on pharmacotherapy, 2014
• Use of cethromycin, a new ketolide, for treatment of community-acquired respiratory infections Expert opinion on investigational drugs, 2008
• Short-course antimicrobial therapy of respiratory tract infections Drugs, 2003
• Chronic obstructive pulmonary disease: clinical signs and infections British journal of nursing (Mark Allen Publishing), 2006
• Bronchial hyperresponsiveness and bacterial respiratory infections Clinical therapeutics, 1991
• Clinical manifestations of Chlamydia pneumoniae infections La Revue de medecine interne, 1996
• Treatment of community-acquired lower respiratory tract infections in adults The European respiratory journal. Supplement, 2002
• Faropenem: review of a new oral penem Expert review of anti-infective therapy, 2007
• Amoxicillin-potassium clavulanate, a beta-lactamase-resistant antibiotic combination Clinical pharmacy, 1984
• Chlamydia pneumoniae infections Kekkaku : [Tuberculosis], 2006
• Place of biomarkers in the management of pulmonary infections Revue des maladies respiratoires, 2019
• Moxifloxacin: clinical efficacy and safety American journal of health-system pharmacy : AJHP : official journal of the American Society of Health-System Pharmacists, 2001
• The clinical and integrated management of COPD. Sarcoidosis, vasculitis, and diffuse lung diseases : official journal of WASOG, 2014
• The role of respiratory infections in chronic obstructive pulmonary disease Medizinische Klinik (Munich, Germany : 1983), 2007
• Procalcitonin-guided diagnosis and antibiotic stewardship revisited BMC medicine, 2017
• Ketolides in the treatment of respiratory infections Expert opinion on pharmacotherapy, 2002
• Telithromycin: the first ketolide antimicrobial Clinical therapeutics, 2005
• Atypical pathogens and respiratory tract infections The European respiratory journal, 2004
• Future antibiotic trials Seminars in respiratory infections, 2000
• Antimicrobial resistance in Haemophilus influenzae Clinical microbiology reviews, 2007
• Azithromycin and lower respiratory tract infections Expert opinion on pharmacotherapy, 2005
• Clinical Pharmacokinetics and Pharmacodynamics of Delafloxacin European journal of drug metabolism and pharmacokinetics, 2019
• Clinical studies of garenoxacin International journal of antimicrobial agents, 2008
• Faropenem medoxomil The Annals of pharmacotherapy, 2008
• Inter-society consensus for the management of respiratory infections: acute bronchitis and chronic obstructive pulmonary disease Medicina, 2013
• Optimizing of antibiotics policy in the Netherlands. III. SWAB guidelines for antimicrobial therapy in adults hospitalized with bronchitis. Foundation Antibiotics Policy Work Group Nederlands tijdschrift voor geneeskunde, 1998
• Evaluation of new anti-infective drugs for the treatment of respiratory tract infections. Infectious Diseases Society of America and the Food and Drug Administration Clinical infectious diseases : an official publication of the Infectious Diseases Society of America, 1992
• Severe Pulmonary Cryptococcosis in an Immunocompetent Patient Presenting With Acute Respiratory Failure Cureus, 2026
• A suspicious case of coagulation disorder caused by vitamin K deficiency associated with fasting and antibiotics Nihon Ronen Igakkai zasshi. Japanese journal of geriatrics, 2019
• Indirect immunofluorescence reaction study of systemic and local humoral immunity in patients with chronic inflammatory lung disease. I. Serological study results with Streptococcus pneumoniae autostrains Zhurnal mikrobiologii, epidemiologii i immunobiologii, 1981
• Nocardia cyriacigeorgica Infection in a COPD Patient Clinical laboratory, 2025
• Effectiveness of ceftizoxime on various infections in patients with underlying diseases The Japanese journal of antibiotics, 1984
• Stenotrophomonas maltophilia Infection in a Patient with Acute Exacerbation of Chronic Obstructive Pulmonary Disease (COPD): A Colonizer or True Infection? The American journal of case reports, 2020
• Experience using cefpirome in patients with infections of the bronchopulmonary system Antibiotiki i khimioterapiia = Antibiotics and chemoterapy [sic], 1996
• Enterovirus-Human-Rhinovirus Infection Leading to Acute Respiratory Distress Syndrome: A Case Report Cureus, 2022
• Acute exacerbations of chronic bronchitis Hospital practice (1995), 1997
• Severe pseudouveitis associated with moxifloxacin therapy Journal francais d'ophtalmologie, 2013
• Systemic lupus erythematosus (SLE) pneumonitis mimicking swine influenza pneumonia during the swine influenza (H1N1) pandemic Heart & lung : the journal of critical care, 2011
• Primary care challenges in the management of respiratory tract infections JAAPA : official journal of the American Academy of Physician Assistants, 2006
• Moxifloxacin induced fatal hepatotoxicity in a 72-year-old man: a case report Cases journal, 2009
• Moxifloxacin-induced tinnitus in an older adult Therapeutic advances in drug safety, 2018
• Potential interaction between clarithromycin and warfarin The Annals of pharmacotherapy, 1997
• Etiology and treatment of choice of respiratory infections in primary care. Opinion of the physicians of the URANO Group Atencion primaria, 1999
• Longitudinal assessment of sputum microbiome by sequencing of the 16S rRNA gene in non-cystic fibrosis bronchiectasis patients PloS one, 2017
• Bacterial etiology of chronic bronchitis exacerbations treated by primary care physicians Archivos de bronconeumologia, 2006
• Factors influencing the prescription or non-prescription of antibiotics by general practitioners Medecine et maladies infectieuses, 2009
• Nontypeable Haemophilus influenzae in the lower respiratory tract of patients with chronic bronchitis American journal of respiratory and critical care medicine, 2001
• Bronchial inflammation in acute bacterial exacerbations of chronic bronchitis: the role of leukotriene B4 The European respiratory journal, 2000
• Detección del riesgo nutricional y estancia hospitalaria en el anciano hospitalizado Nutrición Hospitalaria, 2021
• Impact of FDA black box warning on fluoroquinolone and alternative antibiotic use in southeastern US hospitals Infection control and hospital epidemiology, 2019
• The clinical evaluation of piperacillin and sulbactam sodium in treatment of respiratory, urinary tracts and other infections in 579 patients Zhonghua nei ke za zhi, 2011
• Preventive effect of an immunomodulator, OM-85 BV, on acute exacerbations of chronic bronchitis in elderly patients. Preliminary results at six months in 291 patients Revue des maladies respiratoires, 1993
• The efficacy and safety of a new ciprofloxacin suspension compared with co-amoxiclav tablets in the treatment of acute exacerbations of chronic bronchitis Respiratory medicine, 1999
• Experience with bronchomunal used in the combined treatment of patients with bronchial asthma and chronic obstructive pulmonary disease Problemy tuberkuleza i boleznei legkikh, 2008
• Comparison of 5-day, short-course gatifloxacin therapy with 7-day gatifloxacin therapy and 10-day clarithromycin therapy for acute exacerbation of chronic bronchitis Clinical therapeutics, 2001
• Five day moxifloxacin therapy compared with 7 day clarithromycin therapy for the treatment of acute exacerbations of chronic bronchitis The Journal of antimicrobial chemotherapy, 1999
• Prospective observational study of patient-reported outcomes for azithromycin versus usual care in the treatment of bacterial acute exacerbation of chronic bronchitis Clinical therapeutics, 2005
• Prophylaxis for acute exacerbations of chronic bronchitis using an antibacterial sublingual vaccine obtained through mechanical lysis: a clinical and pharmacoeconomic study Acta bio-medica : Atenei Parmensis, 2003
• Efficacy of oral ciprofloxacin vs. clarithromycin for treatment of acute bacterial exacerbations of chronic bronchitis. The Bronchitis Study Group Clinical infectious diseases : an official publication of the Infectious Diseases Society of America, 1998
• A comparison of a five-day regimen of cefdinir with a seven-day regimen of loracarbef for the treatment of acute exacerbations of chronic bronchitis International journal of clinical practice, 2000
• Efficacy and tolerability of twice-daily ciprofloxacin 750 mg in the treatment of patients with acute exacerbations of chronic bronchitis and pneumonia Clinical therapeutics, 1998
• Equal effectiveness of older traditional antibiotics and newer broad-spectrum antibiotics in treating patients with acute exacerbations of chronic bronchitis Southern medical journal, 2003
• Multicenter evaluation of the efficacy and safety of gatifloxacin in Mexican adult outpatients with respiratory tract infections Advances in therapy, 2000
• Pharmacokinetic and pharmacodynamic aspects of oral moxifloxacin 400 mg/day in elderly patients with acute exacerbation of chronic bronchitis Clinical pharmacokinetics, 2006
• Causative role of infections with viruses or atypical pathogens in acute exacerbations of chronic bronchitis less frequent than expected Nederlands tijdschrift voor geneeskunde, 1996
• Effect of pneumococcal vaccination: a comparison of vaccination rates in patients with bacteremic and nonbacteremic pneumococcal pneumonia Clinical infectious diseases : an official publication of the Infectious Diseases Society of America, 2006
• A prospective study of infections with atypical pneumonia organisms in acute exacerbations of chronic bronchitis Annals of the Academy of Medicine, Singapore, 1999
• Comparative clinical and microbiological study of amoxycillin-clavulanic acid and ciprofloxacin in acute purulent exacerbations of chronic bronchitis The Journal of hospital infection, 1992